The first human-to-human heart transplant was performed at Groote Schuur Hospital in Cape Town, South Africa, on December 3, 1967. The surgeon was Christiaan Barnard, a 45-year-old South African who had trained in the United States, and his patient was Louis Washkansky, a 53-year-old man with severe heart failure who received the heart of Denise Darvall, a 25-year-old woman fatally injured in a car accident.1PubMed Central. Christiaan Barnard-The surgeon who dared: The story of the first human-to-human heart transplant But the full story of “where” the first heart transplant happened reaches well beyond Cape Town, stretching across continents and decades of groundwork that made Barnard’s operation possible.
What Happened at Groote Schuur Hospital
Washkansky had been hospitalized with end-stage heart failure when Darvall was brought in after being struck by a car. Barnard led a team of about thirty people through a marathon operation that had never been attempted on a living human before. The transplanted heart was restarted with electric shock and began beating in Washkansky’s chest. He woke up, talked, and initially seemed to recover.2European Heart Journal. Fifty years of heart transplantation: A journey of courage, innovation and persistence, celebrated in Cape Town But to prevent his body from rejecting the new organ, doctors suppressed his immune system heavily, and eighteen days later he died of pneumonia. His weakened defenses simply could not fight the infection.
Despite the short survival, the operation was a global sensation. Barnard became an overnight celebrity, and the idea that a human heart could be moved from one person to another captured public imagination in a way few medical advances ever have. The transplant was described in the press as “spare part surgery,” a concept that seemed pulled from science fiction.3Journal for the Theory of Social Behaviour. Messiahs, Pariahs, and Donors: The Development of Social Representations of Organ Transplants Within weeks, Barnard performed a second transplant. That patient, Philip Blaiberg, lived an active life for almost nineteen months, offering stronger proof that the procedure could work.1PubMed Central. Christiaan Barnard-The surgeon who dared: The story of the first human-to-human heart transplant
Why Cape Town and Not the United States
The surgical techniques behind heart transplantation were largely developed in American laboratories, so many people assume the first operation must have happened in the United States. Norman Shumway and Richard Lower, working at Stanford University, had spent years perfecting the method of removing a heart and sewing a donor heart into its place in dogs.4PubMed Central. A Pioneer of Cardiothoracic Surgery – the Brazilian Northeast Heart Transplant Program Barnard had visited Shumway’s lab and learned directly from this work. By the mid-1960s, Shumway was widely expected to be the one who would attempt the first human transplant.
So why did Barnard beat him to it? Several factors converged. American hospitals faced stricter institutional review processes, and the legal definition of death was murkier in the United States. At the time, there was no widely accepted concept of brain death. A surgeon who removed a heart from a patient whose body was still technically alive could face murder charges. South Africa’s legal environment was less constraining on this front, and Barnard moved quickly once a suitable donor became available. The gap was not one of skill or knowledge but of timing, bureaucratic barriers, and a willingness to act first.
The Earlier Attempt Nobody Remembers
Strictly speaking, the very first time a heart was transplanted into a human being happened three years before Barnard’s operation, and it did not involve a human donor at all. On January 23, 1964, James Hardy at the University of Mississippi transplanted a chimpanzee heart into a 68-year-old man who was in terminal shock from severe coronary artery disease. The intended human donor was on a respirator but had not died, so Hardy made the controversial decision to use the primate heart instead.5The American Journal of Cardiology. The first heart transplant in man: Developmental animal investigations with analysis of the 1964 case in the light of current clinical experiences The chimpanzee heart was too small to support the man’s circulation, and the patient died within about two hours.
Hardy faced intense criticism, both from the public and from fellow surgeons, for using an animal heart. The backlash was severe enough that it likely slowed the progress of cardiac transplantation in the United States by several years. When people ask where the first heart transplant was performed, they almost always mean the first human-to-human operation, which is Barnard’s. But Hardy’s attempt in Mississippi is a significant footnote: it showed that the surgical mechanics were feasible while revealing the enormous immunological gap between species.
The Flurry That Followed
Barnard’s success set off a global rush. Just three days after the Cape Town operation, Adrian Kantrowitz in New York attempted an infant heart transplant.6PubMed. Origins of neonatal heart transplantation: an historical perspective Shumway performed his first human transplant at Stanford in January 1968. Within a year, more than a hundred heart transplants had been carried out at hospitals around the world. Surgeons in Houston, Paris, London, and Bombay all attempted the procedure.
The results were grim. The vast majority of these early recipients died within weeks or months, primarily from organ rejection. Surgeons understood the basic immune problem but had almost no effective tools to manage it. The crude immunosuppressive drugs available at the time either failed to prevent rejection or left patients fatally vulnerable to infections, exactly the dilemma that had killed Washkansky. By the early 1970s, enthusiasm had collapsed. Most transplant programs shut down, and the procedure was widely considered a noble failure. Only a handful of centers, Stanford chief among them, kept performing transplants and refining their approach through this dark period.
The Drug That Changed Everything
Heart transplantation was rescued in the early 1980s by cyclosporine, an immunosuppressive drug derived from a soil fungus. Cyclosporine worked in a fundamentally different way from earlier drugs: it could dampen the specific immune response that attacks a foreign organ without obliterating the rest of the immune system. Stanford introduced cyclosporine-based treatment in 1980, and the difference was dramatic.7PubMed. Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience
The numbers tell the story clearly. At Stanford, patients transplanted before cyclosporine had a ten-year death rate from rejection of about 14 percent. Once cyclosporine was introduced, that figure dropped to 7 percent, and with further refinements in the late 1980s it fell to 5 percent.8PubMed. Thirty years of cardiac transplantation at Stanford university Looking at overall survival across that institution’s full experience from 1968 to 2007, one-year survival rose from around 43 percent in the early era to over 90 percent.9American Journal of Transplantation. Characteristics of Long-Term Survivors 20 Years After Heart Transplantation—A 40-Year Single-Center Experience Transplant programs reopened worldwide, and heart transplantation went from experimental curiosity to established therapy.
How a Heart Gets from Donor to Recipient
One of the less visible challenges of heart transplantation has always been keeping the donor heart alive outside the body. Unlike kidneys or livers, which can tolerate hours of cold storage, a heart is far more sensitive to time without blood flow. The standard approach for decades has been to flush the heart with a cold preservation solution and pack it in ice, which gives surgical teams roughly four to six hours to transport it and sew it into the recipient.
That time window has shaped the entire logistics of transplantation: donor and recipient need to be within a certain geographic range, and transport by helicopter or chartered jet is common. Newer preservation technologies aim to extend this window. Some systems now keep the donor heart warm and beating during transport, perfusing it with oxygenated blood. These advances matter because they allow organs to be shared across wider distances, potentially reaching sicker patients who would otherwise never get matched.10PubMed Central. Heart Donation and Preservation: Historical Perspectives, Current Technologies, and Future Directions
The Surgical Foundations That Made It Possible
Long before anyone seriously considered transplanting a whole heart, the basic surgical toolkit had to be invented. The single most important technical advance was the ability to sew blood vessels together reliably. Alexis Carrel, a French surgeon working in the early 1900s, developed the triangulation technique for joining blood vessels end to end. This method, which is still used in operating rooms today, earned him the Nobel Prize in 1912.11PubMed. Alexis Carrel (1873-1944): visionary vascular surgeon and pioneer in organ transplantation Without Carrel’s vascular suture work, organ transplantation of any kind would have been impossible. He also performed some of the earliest experimental organ transplants in animals, showing that organs could be moved between bodies and briefly function, even though rejection inevitably destroyed them.
The other essential precondition was the heart-lung bypass machine, developed in the 1950s, which allowed surgeons to stop a patient’s heart while a machine temporarily took over the job of circulating and oxygenating blood. Barnard’s operation, Shumway’s research, and every heart transplant since have depended on this technology.
The Apartheid Backdrop
The fact that the first heart transplant happened in apartheid-era South Africa was not incidental to its story. The South African government was eager to present the country as modern and technologically advanced, and Barnard’s triumph served that propaganda purpose well. But the transplant also raised uncomfortable questions about race, medicine, and power.
After Barnard’s initial successes, discussions about donor selection at an international heart transplantation symposium he organized in Cape Town touched on capital punishment as a source of donor organs, a conversation in which the death penalty served as a proxy for race in a country where the justice system was overtly discriminatory.12Law and History Review. Heart Transplants, Legislating Death, and Disruptive Anti-Apartheid Advocacy South Africa even attempted to legislate the use of organs from “living donors” in “authorized institutions,” a chilling concept given the political context.
One figure who became entangled in this complicated legacy was Hamilton Naki, a Black laboratory technician at the University of Cape Town. Despite having only a primary school education, Naki became highly skilled in experimental animal surgery, including liver transplantation in animals. After Barnard’s death, claims circulated that Naki had played a direct role in the 1967 transplant itself, a narrative that highlighted the injustice of apartheid-era credit and recognition. The University of Cape Town later awarded Naki an honorary Master of Medicine degree, and he received one of South Africa’s highest civil honours. However, the extent of his involvement in the human operation itself remains a matter of historical dispute.13The Bulletin of the Royal College of Surgeons of England. Hamilton Naki, his life, and his role in the first heart transplant
Brain Death and the Legal Puzzle
Heart transplantation forced the medical and legal worlds to confront a question they had been able to avoid: when is a person actually dead? Before 1967, death was defined by the irreversible cessation of heartbeat and breathing. But to transplant a heart, you need the donor’s heart to still be beating, or at least viable, at the moment it is removed. This created an obvious paradox.
The problem was urgent. In 1968, a Harvard committee published a landmark report proposing the concept of brain death: the idea that a person could be declared dead when all brain function had permanently ceased, even if machines were keeping the heart beating and the lungs inflating. This framework became the legal standard in most countries over the following decades and remains the basis for organ donation today. Barnard’s transplant did not create this debate out of nothing, but it made it impossible to postpone. The legal and ethical infrastructure that governs organ donation worldwide grew directly from the questions his operation forced into the open.
Groote Schuur’s Longer Track Record
It is worth noting that the Cape Town program was not a one-hit wonder. While Washkansky’s eighteen-day survival made headlines, the program’s subsequent results were better than many people realize. Among Groote Schuur Hospital’s first ten heart transplant recipients, four survived more than a year. Two of those early patients lived for thirteen and twenty-three years, respectively.14PubMed Central. The first human heart transplant and further advances in cardiac transplantation at Groote Schuur Hospital and the University of Cape Town These outcomes, achieved before cyclosporine existed, suggest that the Cape Town team was not merely lucky or reckless. They were genuinely skilled and continued to refine their approach long after the initial media frenzy died down.
From Pig Hearts to the Present
The shortage of human donor hearts has never been solved. Roughly half of patients on the transplant waiting list in many countries either die or become too sick for surgery before a heart becomes available. This persistent gap has driven researchers back to an idea that James Hardy first tried in 1964: using animal hearts.
In January 2022, surgeons at the University of Maryland transplanted a genetically modified pig heart into a 57-year-old man who was dependent on life support and had no other options. The pig had been engineered with ten individual gene edits designed to make its heart more compatible with the human immune system and less likely to trigger rejection or dangerous viral infections.15PubMed Central. Genetically Modified Porcine-to-Human Cardiac Xenotransplantation The patient survived about two months before the heart failed. A second patient received a similar pig heart later and survived somewhat longer.
These procedures are still deeply experimental, and long-term pig-to-human heart transplantation remains far from routine. But the genetic engineering tools available today are vastly more sophisticated than anything Hardy could have imagined. Where his chimpanzee heart failed within hours because of the raw immunological mismatch between species, researchers can now systematically edit out the specific molecular triggers that cause rejection. Several more genetically modified pig heart transplants are in various stages of planning and regulatory review. Whether this approach eventually supplements or even replaces human donor hearts is one of the biggest open questions in transplant medicine.
What Groote Schuur Looks Like Today
Groote Schuur Hospital still stands on the slopes of Devil’s Peak in Cape Town, and it still performs heart transplants. The hospital maintains a museum dedicated to the 1967 operation, housed in the old building where the transplant took place, with the original operating theatre preserved. For visitors, it offers a grounding sense of scale: the room is surprisingly small, the equipment looks rudimentary by modern standards, and it is hard to believe that an operation so world-altering happened in such modest surroundings. The museum is one of Cape Town’s lesser-known landmarks, but for anyone interested in medical history, it brings the story to life in a way that reading about it cannot quite match.